Akashi Therapeutics Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Akashi Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. The company's treatments promote healthy muscle regeneration and build muscle mass and strength, enabling patients to transform their situations from a fatal, aggressive muscle-wasting disease to a chronic, manageable condition.
Contact Information
Website
www.akashirx.comCorporate Office
- 245 First Street
- 18th Floor
- Cambridge, MA 02142
- United States
Corporate Office
- 245 First Street
- 18th Floor
- Cambridge, MA 02142
- United States
Akashi Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Mar-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 03-Jul-2014 | Completed | Generating Revenue | |||
| 2. Grant | $1M | $6M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 10-Apr-2013 | $6M | $6M | Completed | Generating Revenue |
Akashi Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Akashi Therapeutics Comparisons
Industry
Financing
Details
Akashi Therapeutics Competitors (1)
One of Akashi Therapeutics’s competitors is AOBiome Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AOBiome Therapeutics | Formerly VC-backed | Cambridge, MA |
Akashi Therapeutics Patents
Akashi Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160250188-A1 | Methods for treatment of muscular dystrophies | Inactive | 25-Oct-2013 | ||
| US-20190167640-A1 | Methods for treatment of muscular dystrophies | Inactive | 25-Oct-2013 | ||
| AU-2013237881-A1 | Dosage forms of halofuginone and methods of use | Active | 29-Mar-2012 | ||
| AU-2013237881-B2 | Dosage forms of halofuginone and methods of use | Inactive | 29-Mar-2012 | ||
| AU-2018200167-A1 | Dosage forms of halofuginone and methods of use | Inactive | 29-Mar-2012 | A61K9/4891 |
Akashi Therapeutics Signals
Akashi Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hadasit | Venture Capital | Minority | ||
| Charley's Fund | Not-For-Profit Venture Capital | |||
| Nash Avery Foundation | Other |
Akashi Therapeutics Acquisitions (2)
Akashi Therapeutics’s most recent deal was a Merger/Acquisition with Tonus Therapeutics. The deal was made on 15-Sep-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tonus Therapeutics | 15-Sep-2014 | Merger/Acquisition | Drug Discovery | ||
| Collgard Biopharmaceuticals | 01-Mar-2011 | Merger/Acquisition | Pharmaceuticals |
Akashi Therapeutics FAQs
-
When was Akashi Therapeutics founded?
Akashi Therapeutics was founded in 2010.
-
Where is Akashi Therapeutics headquartered?
Akashi Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Akashi Therapeutics?
Akashi Therapeutics has 2 total employees.
-
What industry is Akashi Therapeutics in?
Akashi Therapeutics’s primary industry is Drug Discovery.
-
Is Akashi Therapeutics a private or public company?
Akashi Therapeutics is a Private company.
-
What is Akashi Therapeutics’s current revenue?
The current revenue for Akashi Therapeutics is .
-
How much funding has Akashi Therapeutics raised over time?
Akashi Therapeutics has raised $7.5M.
-
Who are Akashi Therapeutics’s investors?
Hadasit, Charley's Fund, and Nash Avery Foundation have invested in Akashi Therapeutics.
-
Who are Akashi Therapeutics’s competitors?
AOBiome Therapeutics is a competitor of Akashi Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process